Snowball logo
logo
BBIO_logo

BridgeBio Pharma, Inc

BBIO β€’ NASDAQ
$80.40-$0.67Β  (0.83%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
69.7277.659.303221.9502.1691.8
COGS
3.1143.4342.4463.87828.2747.45
Gross Profit
66.674.216.857218473.8644.4
Operating Expenses & Income
Operating Income
(576.6)(512.2)(607.4)(593)(569.1)(543.5)
Total Operating Expenses
643.2586.4614.28111,042.91,187.9
R&D Expenses
451399.5455.7506.5477.5531
Selling General & Admin Expenses
192.2143.2150.6250.9531.2645.9
Earnings from Continuing Operations
Interest Expense
(46.78)(80.44)(81.29)(99.29)(53.1)(89.83)
Interest Income
1.1337.54218.0417.2519.8516.82
Income Tax Expense
52.849.31271.511.1530.555(7.732)
Net Income
Net Income
(562.5)(481.2)(643.2)(535.8)(729.3)(696.2)
Supplemental
EBIT
(539.7)(404.2)(572)(442.9)(681.9)(616.3)
EBITDA
(533.8)(397.4)(565.5)(436.8)(672.9)(602.8)
In millions of USD, except % and values per 1 share